Aims Background Vancomycin is a commonly used antibiotic in the neonatal unit. Its efficacy
correlates directly with the duration of bacterial exposure at therapeutic levels. In our unit, we …

Objective: Describe and assess a continuous infusion dosing scheme of vancomycin
therapy in critically ill children. Design: Retrospective single-center study, January to June …

Objective: To explore the efficacy and safety of vancomycin as measured by
pharmacokinetic/pharmacodynamic parameters in children with severe infection in the …

Purpose To assess the clinical impact of a vancomycin dosing protocol and monitoring tool
on initial dose, dosing interval, and trough concentrations in adult medicine patients …

Vancomycin is a first‐line treatment for β‐lactam‐resistant Gram‐positive bacterial
infections. Understanding the pharmacokinetic (PK) and pharmacodynamic (PD) …

Purpose Quality improvements achieved by applying the systems approach to assess the
clinical effectiveness, operational efficiency, and financial feasibility of a pharmacist …

Vancomycin is widely used in neonatal sepsis but proportion of newborn reaching
recommended concentration is variable. Fluid status impact on vancomycin level remains …

Purpose. This study compared steady-state concentrations achieved with a dosing strategy
using first-dose kinetics to individualize vancomycin regimens with the steady-state …

Aim Vancomycin guidelines for therapeutic drug monitoring (TDM) aim to maximise efficacy
while minimising toxicity and resistance. Vancomycin is effective against Staphylococcus …

The American Society of Health-System Pharmacists, the Infectious Diseases Society of
America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases …